Molecular aging of tau: disulfide-independent aggregation and non-enzymatic degradation in vitro and in vivo

Journal of Neurochemistry
Atsushi WatanabeY Ihara

Abstract

Smearing from high-molecular-mass regions to low-molecular-mass regions on western blot is the most striking observation of the tau making up paired helical filaments in brain tissues affected by Alzheimer's disease. Because our previous study showed site-specific deamidation/isomerization in the smeared tau in vivo, a feature of protein aging, recombinant tau was subjected to prolonged (up to 90 days) in vitro incubation. Carboxymethylated tau at approximately 50 kDa gradually disappeared and was converted to dimers and to high- and low-molecular-mass smearing. In addition, the same site-specific deamidation/isomerization as previously identified in the smeared tau in vivo emerged. Most importantly, tau was spontaneously degraded, generating fragments that start from bulky residues next to asparaginyl residues. This spontaneous degradation of tau probably represents non-enzymatic cleavage through the formation of succinimide intermediates. Similar degradation products starting from the bulky residues next to asparaginyl residues were found in the smeared tau in vivo partially purified from the homogenates from Alzheimer's disease brains.

Citations

Mar 6, 2009·Cellular and Molecular Neurobiology·Peter FilipcikMichal Novak
Mar 22, 2013·Molecular Neurobiology·Santosh JadhavMichal Novak
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Eva-Maria Mandelkow, Eckhard Mandelkow
Jun 22, 2012·International Journal of Alzheimer's Disease·Natalia Crespo-BielFred Van Leuven
Dec 4, 2015·Nature Reviews. Neuroscience·Yipeng Wang, Eckhard Mandelkow
Aug 26, 2006·The European Journal of Neuroscience·Martin CenteMichal Novak
Jun 15, 2007·The European Journal of Neuroscience·Naruhiko SaharaAkihiko Takashima
Apr 8, 2017·Acta Neuropathologica·Tong GuoDiane P Hanger
Mar 3, 2018·International Journal of Molecular Sciences·Almudena Fuster-MatanzoJesús Ávila
Jun 15, 2007·The Journal of Biological Chemistry·Diane P HangerBrian H Anderton
Aug 18, 2005·Journal of Neuropathology and Experimental Neurology·Tomohiro MiyasakaYasuo Ihara
Apr 25, 2020·Current Alzheimer Research·Adrianna WysockaGrazyna Niewiadomska
Dec 4, 2019·The Biochemical Journal·Michael G FriedrichRoger J W Truscott
Jul 28, 2010·Biochemical Society Transactions·Yipeng WangEckhard Mandelkow
Jul 28, 2020·International Journal of Molecular Sciences·Elena VacchiGiorgia Melli
Oct 21, 2020·Cellular and Molecular Life Sciences : CMLS·Yifan ZengYongqi Huang
Feb 14, 2021·Cell Communication and Signaling : CCS·Shweta Kishor SonawaneSubashchandrabose Chinnathambi
Apr 4, 2021·International Journal of Molecular Sciences·Michael G FriedrichRoger J W Truscott
Apr 21, 2019·International Journal of Biological Macromolecules·Anuradha Venkatramani, Dulal Panda
Aug 18, 2021·The Protein Journal·Dan WangYongqi Huang
Nov 26, 2020·Biochemistry·Abhishek Ankur BalmikSubashchandrabose Chinnathambi
Oct 23, 2018·ACS Chemical Neuroscience·Dandan Chu, Fei Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.